Clinical Trial

Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A study of the iStent Infinite product in the treatment of open-angle glaucoma vs competitor
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-11-18; most recent amendment 2024-08-13.
Status change: Recruiting → Active, Not Recruiting 2023-02-08
Status change: Withdrawn → Recruiting 2022-12-07
Status change: Not Yet Recruiting → Withdrawn 2021-11-24
Trial Details
NCT Number NCT05127551
Lead Sponsor Glaukos Corporation
Conditions Glaucoma, Glaucoma, Open-Angle
Enrollment 179 participants
Start Date 2021-11-27
Primary Completion 2024-02-29 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-15